Site Map
Centres of ExcellenceMassachusetts General Hospital / Harvard Medical School, USA,
Bispebjerg Hospital Copenhagen, Denmark,
Federal Teaching Hospital Feldkirch, Austria,
University of Geneva, Switzerland,
University of Salzburg, Austria,
IVF centres Prof. Zech Bregenz, Austria About usCompany,
The Big Picture,
History,
Management TeamBoardReinhard Braun, Chairman of the Board,
Herbert Zech, Prof., MD, IVF-Specialist, Board Member,
William D. Dearstyne, MBA, Board Member,
Werner Braun, Mag. pharm., Pharmacist, Board Member,
Michael Armbrüster, BSc, Board Member,
Burkhard Feurstein, MSc, Board Member,
Manfred Asamer, PhD, Board Member,
Werner Lanthaler, PhD, Board Member,
Christof Böhler, PhD, Chief Executive Officer Advisory BoardCareer Opportunities,
Contact,
General terms and conditions Events & NewsConferencesAmgen Device Fair,
BEAUTY DÜSSELDORF,
BEAUTY FORUM,
6th ANNUAL EUROPEAN LIFE SCIENCE CEO FORUM PARTNERING & INVESTING,
BIO-Europe 2012,
Biotech in Europe Investor Forum,
EADV Prague 2012,
LaserInnsbruck 2012,
4th EPSRC,
4th UNI meets Pharma,
4th International Scar Club Meeting,
BioEurope Spring 2012 - Download our Presentation,
World Immune Regulation Meeting,
European Life Science CEO Forum,
16th annual DDP - Download our Presentation, ,
Bio Europe 2011 - Download our Presentation,
20th EADV Congress,
20. Tagung der Deutschen Dermatologischen lasergesellscaft (DDL),
Biopharm USA 2011 - Download our Presentation,
Bio Europe Spring 2011,
15th Drug Delivery Partnerships Press releasesArchiveHuman cutaneous tolerability study concluded positively,
Nomination for Swiss Medtech Award 2007,
New web animation showing how the P.L.E.A.S.E.® platform works,
Pantec Biosolutions successfully initiates Series A Financing Round,
Pantec Biosolutions presented new drug delivery platform and supporting preclinical data at Drug Delivery Partnerships 2008,
Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform,
Pantec Biosolutions appoints new Board members,
Pantec Biosolutions receives ISO 13485 certification,
Pantec Biosolutions Receives Marketing Clearance for P.L.E.A.S.E.®,
Pantec Biosolutions Expands Scientific Advisory Board,
Pantec Biosolutions reports successful Phase I study into the delivery of triptorelin using P.L.E.A.S.E.® technology,
Pantec Biosolutions Granted European Patent for P.L.E.A.S.E.®,
Pantec Biosolutions is Granted SME Status in EU,
Pantec Biosolutions reports successful Phase I for delivery of FSH using P.L.E.A.S.E.®,
Pantec Biosolutions' P.L.E.A.S.E. Professional® Receives Marketing Authorisation,
Pantec Biosolutions Closes CHF 20 Million Financing,
Pantec Biosolutions receives "Honourable Mention" in red dot awards,
Pantec Biosolutions to exhibit MEDICA 2010 World Forum in Düsseldorf, Germany on 17-20 November 2010,
Pantec Biosolutions Achieves Clinical Efficacy POC for Delivery of urinary FSH using P.L.E.A.S.E.®,
Pantec Biosolutions reports first successful IVF pregnancy using P.L.E.A.S.E.® -FSH patch February 7, 2011,
September 7, 2011,
September 28, 2011,
October 19, 2011,
November 16, 2011,
January 24, 2012,
January 26, 2012,
March 22, 2012,
July 16, 2012,
January 17, 2013 Press ArticlesPress Article ArchiveMarch 13, 2008,
April 2, 2008,
May, 2008,
June 15, 2008,
June 27, 2008,
July, 2008,
August, 2008,
September, 2008,
September, 2008,
September, 2008,
February, 2009,
December, 2009,
November, 2011 Disclaimer,
Conference Presentations